Edematous form of the Hemolytic Disease of the Fetus and Newborn
https://doi.org/10.21886/2219-8075-2019-10-4-105-110
Abstract
Clinical observation of a premature newborn patient with an edematous form of the Hemolytic Disease is presented. A feature of this case is its relative rarity in view of the favorable outcome of the most severe form of hemolytic disease in an extremely severe initial condition of the fetus.
About the Authors
M. G. Pukhtinskaya
Scientifically Research Institute of Obstetrics and Pediatrics, Rostov State Medical University
Dr. Sci. (Med.), Leading Researcherof Department of Anesthesiology and Resuscitation,
V. V. Estrin
Scientifically Research Institute of Obstetrics and Pediatrics, Rostov State Medical University
Russian Federation
Russian Federation
Dr. Sci. (Med.), Professor, Head of Department of Anesthesiology and Resuscitation,
Yu. A. Porutchikovа
Scientifically Research Institute of Obstetrics and Pediatrics, Rostov State Medical University
Russian Federation
Russian Federation
Chief Medical Officer,
A. V. Simonovа
Scientifically Research Institute of Obstetrics and Pediatrics, Rostov State Medical University
Russian Federation
Russian Federation
Cand. Sci. (Med.), Manager of Intensive Care unit,
References
1. Savelieva GM, Kurtser MA, Panina OB, Sichinava LG, Konoplyannikov AG. Hemolytic disease of the fetus in pregnant women with Rh sensitization. Diagnosis, treatment, prevention. Methodical letter of the Ministry of Healthcare, 2012. (in Russ.)
2. Konoplyannikov AG, Pavlova NG. Isoserological incompatibility of blood of mother and fetus. Hemolytic disease of the fetus and newborns. In: Obstetrics. National leadership. 2015: 324-334. (in Russ.)
3. Qureshi H, Massey E, Kirwan D, Davies T, Robson S, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfusion medicine. 2014;24:8-20. doi: 10.1111/tme.12091
4. Bennardello F, Coluzzi S, Curciarello G, Todros T, Villa S, et al. Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn. Blood Transfus. 2015;13:109-134. doi: 10.2450/2014.0119-14
5. Bennardello F, Curciarello G. Survey of the prevention and incidence of haemolytic disease of the newborn in Italy. Blood Transfus. 2013;11:518-527.
6. Baybarina EN, Degtyarev DN. Selected clinical guidelines on neonatology. Moscow: GEOTAR-Media, 2016. (in Russ.)
7. Boyko NV, Model GYu, Alekhina VI. Features of adaptation of newborns who have had intrauterine blood transfusions. Kubanskij nauchnyj medicinskij vestnik. 2018;25(3):34-39. (in Russ.)
8. Ivanova AV, Zaharova SJu, Kosovcova NV, Pavlichenko MV, Generalov AE. Specific features of a neonatal period in infants following intrauterine intravascular blood transfusion for fetal hemolytic disease. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2015;60(1):44-48. (In Russ.)
Review
For citations:
Pukhtinskaya M.G., Estrin V.V., Porutchikovа Yu.A., Simonovа A.V. Edematous form of the Hemolytic Disease of the Fetus and Newborn. Medical Herald of the South of Russia. 2019;10(4):105-110. (In Russ.) https://doi.org/10.21886/2219-8075-2019-10-4-105-110
Views:
3246
Email this article 